5 Open Questions About FDA's AI-Assisted Review Plans
By Lisa Dwyer, Jeffrey Shapiro and McKenzie Cato · June 12, 2025, 6:20 PM EDT
On May 8, the U.S. Food and Drug Administration announced the completion of a generative artificial intelligence pilot program for scientific reviewers....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login